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Opioid Use Disorder (OUD) and Preterm Birth  
• OUD is linked to increases in the likelihood of preterm birth, defined as delivery before 
37 weeks gestation (Patrick, 2012).
• Preterm birth is responsible for 85% of perinatal deaths, so opioid use poses increased 
risks on the health of the mother and the baby (de Bernabe, 2004; Kramer, 2000; Norwitz & Robinson, 2001).  
• Management of OUD with methadone during pregnancy makes women 4.32 times more 
likely to give birth preterm than controls (Clearly, 2011).
• Research has yet to identify if there is any increased risk for preterm birth in women who 
use opioids during pregnancy and self-report borderline features . 
Borderline Personality Disorder (BPD) and Preterm Birth
• BPD is a psychological disorder with symptoms that include impulsivity in at least two 
areas that are self-damaging, such as spending, reckless driving, binge eating, etc. 
• Women may also show borderline features without a diagnosis of BPD due to lack of 
access to care or unwillingness to seek care.
• Women with BPD are more likely to experience preterm birth than individuals without 
BPD due to specific risks imposed by their behaviors and experiences (Blankley, Galbally, Snellen, 
Power, & Lewis, 2015).
• E.g. Identity disturbance in pregnant women with BPD challenges the transition to 
motherhood, which may make women less likely to engage in prenatal care and thus 
be more likely to deliver preterm  (Vintzileos, Ananth, Smulian, Scorza, Knuppel, 2002).
• 16.78% of women with BPD gave birth preterm compared to 7.48% of women in the 
general population (Pre-Miron, Czuzoj-Shulman, Oddy, Spence, and Abenhaim, 2016).
• While it is known that women with BPD are at risk for preterm birth and that BPD is a 
comorbidity for opioid use, no studies have evaluated BPD or borderline features and 
preterm birth in the context of opioid use.
OUD, BPD, and Preterm Birth 
• Because BPD predisposes women to engage in risky behaviors, women with BPD are 
more likely to use substances.  If using while pregnant, the risks of preterm birth is 
heightened more than just if the woman has BPD or OUD alone. 
• Research has yet to examine the increased risk that BPD or borderline features may  
have on preterm birth in a woman who is pregnant and using opioids. 
The Present Study 
• Sought to address these aforementioned gaps in the literature by examining how 
borderline features such as affective instability, identity disturbance, presence of negative 
relationships, and self-impulsivity will moderate the relationship between opioid use and 
preterm birth.
• We expect to replicate findings from past studies and hypothesize that women who 
used opioids in pregnancy would be more likely to give birth preterm (hypothesis A) 
and at lower gestational age (hypothesis B) than high risk medical comparisons.
• We expect to replicate findings from past studies and hypothesize that women who 
self-report borderline features in our study will be more likely to give birth preterm 
(hypothesis A) and at lower gestational age (hypothesis B) than high risk medical 
comparisons.
• Since women who show borderline features or have BPD are at a greater risk for 
preterm birth because of their behaviors and experiences, and since women with BPD 
are more likely to use opioids, we hypothesize that borderline features will be 
associated with a stronger relationship between opioid use and preterm birth. 
Participants 
• 90 high-risk women with OUD (n =53) or other medical 
conditions (n = 37). 
• Other medical conditions included obesity, high blood 
pressure, multiple gestation, and heart disease. 
Procedure
• Recruited from high-risk obstetrics clinic by flyers in clinic 
waiting room and word of mouth from the physicians working in 
the clinic.
• Patient interested greeted in separate room before or after her 
appointment with her doctor.
• Upon enrollment, participant completed a questionnaire packet, 
and research assistant obtained information from participant’s 
medical chart.
Measures 
• Demographics: The demographics assessed included race, 
employment status, relationship status, and gestational age.
• Borderline Features were measured using The Personality 
Inventory – Borderline Features Scale (PAI-BOR). A score of 38 
or above would be equivalent to a BPD diagnosis; (Morey, 1991; 
Trull, 1995)
• Ex. “My mood can shift quite suddenly” (affective instability) 
or “My attitude about myself changes a lot” (identity 
problems). 
• Opioid Use was verified through a urine screen or a prescription 
for opioid withdrawal management medication, buprenorphine. 
• Preterm Birth was a categorical variable obtained from medical 
records. A continuous variable of gestational age at birth was 
assessed.
• Preterm birth was defined as birth before 37 weeks 
gestation. 
Conclusions 
• OUD does not impose a risk of preterm birth over and above what is expected 
for a high-risk pregnancy. 
• It is likely that risk of preterm birth from BPD does not increase simply based 
off an increase in self-reported symptoms, but rather once self-reported 
symptoms reach the threshold used to approximate a diagnosis. 
• This is the first study we know of to date to use a high-risk control group as 
opposed to a normative control group. 
• This control group allows for analysis of the risks of opioid use in comparison 
to those with a high-risk pregnancy from other medical conditions. 
Future Directions
• With a larger sample, we could better understand how the differences in the 
potential ways of using opioids during pregnancy (illicit use, prescribed use, 
etc.) may be related to the rates of preterm birth.
• With a more diverse sample, we would be more able to generalize our results 
to all groups of women and better understand how these variables interact in 
the population as a whole. 
Introduction Hypotheses
• Opioid use during pregnancy is predictive of preterm birth 
(H1A) and gestational age at birth (H1B).
• Borderline personality disorder is predictive of preterm birth 
(H2A) and gestational age at birth (H2B)
• Borderline features moderate the relationship between opioid 




• Analytic Strategy: T-tests and chi-square tests were used to evaluate 
continuous variables and categorical variables, respectively. Binomial logistic 
regression was used to assess the relationship between both OUD and BPD 
and preterm birth. ANOVA was used to evaluate whether OUD predicted 
gestational age at birth. The Pearson product-moment correlation was used to 
evaluate the relationship between borderline features and gestational age at 
birth. Binomial linear regression was used to evaluate the moderation of BPD 
between OUD and preterm birth. 
• H1A: Opioid use will predict preterm birth: Not supported 
• H1B: Opioid use will predict gestational age: Not supported. 
• OUD gave birth at 38.12 weeks on average; control group gave 
birth at 37.65 weeks on average. 
• H2A: BPD will predict preterm birth: Supported. 
• χ² (1)= 4.933, p < .05.
• H2B: BPD will predict gestational age: Not supported.
• H3: Borderline features moderate the relationship between opioid use and 
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